2021 annual financial data

Pliant Therapeutics, Inc. 2021 Net margin

Pliant Therapeutics, Inc. 2021 net margin with verified reported values.

Direct answer

Net margin was -236.49%.

Operating income was -19,986,000 USD and net income was -17,907,000 USD.
Operating cash flow was -75,443,000 USD.

Get free Pliant Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,572,000 USD
Operating income
-19,986,000 USD
Net income
-17,907,000 USD
Operating cash flow
-75,443,000 USD